Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Journal of Dairy Science
|
March 1, 2016
Novel and successful free comments method for sensory characterization of chocolate ice cream: A comparative study between pivot profile and comment analysis
Fernando G A Fonseca, Erick A Esmerino, Elson R Tavares Filho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer
V Valero, F A Holmes, R S Walters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer
V Valero, A U Buzdar, R L Theriault, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Journal of Dairy Science
|
March 1, 2016
Novel and successful free comments method for sensory characterization of chocolate ice cream: A comparative study between pivot profile and comment analysis
Fernando G A Fonseca, Erick A Esmerino, Elson R Tavares Filho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer
V Valero, F A Holmes, R S Walters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer
V Valero, A U Buzdar, R L Theriault, et al.
Page
of 2